Andel is among companies selling brand-name drugs directly to employers, bypassing pharmacy benefit managers and insurers. Medical Economics spoke with founder and CEO Jay Bregman about the model and what physicians should keep in mind.
Andel is among a growing number of companies that sell brand-name drugs directly to employers, skipping pharmacy benefit managers and insurers. Medical Economics spoke with founder and CEO Jay Bregman to better understand how the model works and what physicians should keep in mind.
Personalise this feed
Your specialty. Your sources. Your digest.
All set up in under 2 minutes.
Personalise this feed
Your specialty. Your sources. Your digest.
All set up in under 2 minutes.